Archive: 27/02/2013

IV fluids used by NHS responsible for unnecessary deaths

Starch-based intravenous (IV) fluids used by the NHS to treat seriously ill patients are causing unnecessary deaths, according to a new Cochrane systematic review by researchers at the London School of Hygiene & Tropical ...

US drug firm Mylan to buy Indian firm for $1.6 bn

US generic drugs specialist Mylan said Thursday it would buy a unit of India's pharma firm Strides Arcolab for $1.6 billion, boosting its presence in the high-growth injectable drugs market.

page 1 from 9